Sentences with phrase «for squamous»

Other breeds like Collies, Dalmatians, Basset Hounds, and Beagles are all at higher risk for squamous cell carcinomas.

There are a variety of different treatments for squamous cell carcinomas some of which can be performed by your regular veterinarian and others which require a board certified equine ophthalmologist.

During the study, the researchers tracked the pre-and-post treatment diets and ultimate health outcomes of more than 400 cancer patients for an average of 26 months after they were first diagnosed and treated for squamous - cell carcinoma of the head or neck.

14255: STAT3 Signaling During Chemo - Radiation for Squamous Cell Carcinoma of the Head and Neck 14340: A Phase II, Randomized, Open - Label, Multi-Center, Global Study of MEDI4736 Monotherapy, Tremelimumab Monotherapy, and MEDI4736 in Combination with Tremelimumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) 14258: Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)

Both drugs are approved for treating metastatic melanoma, and Opdivo is also approved for squamous lung cancer.

Not exact matches

For the new trial, hospitals enrolled patients with advanced, squamous non-small cell lung cancer whose disease had progressed despite initial chemotherapy.

Squamous non-small cell lung cancer accounts for 25 to 30 percent of all lung malignancies.

«We'd like to extend this further to examine for driver genes in other types of lung cancer, such as squamous cell lung cancer.»

In the case of head and neck squamous cell carcinoma, for example, high stemness indices correlated with mutations in the gene NSD1.

«Prognostic factors identified for peripheral squamous cell carcinomas of the lung.»

Lung cancer is the most common cause of cancer - related death worldwide and lung squamous cell carcinomas (SCC) account for 20 - 30 % of all NSCLC.

New results from a clinical trial involving more than 900 military veterans at high risk for keratinocyte carcinoma skin cancer provides evidence that using the generic skin cream fluorouacil 5 percent for two to four weeks may reduce the risk of a squamous cell carcinoma (SCC) needing surgery by 75 percent within a year.

The risk of skin cancer increases the more hydrochlorothiazide you have taken throughout your lifetime, and the risk of squamous cell carcinoma was up to seven times greater for people who had taken hydrochlorothiazide in an amount corresponding to > 10 years» use.

The current standard of care for advanced head and neck squamous cell carcinoma involves chemotherapy and radiation.

NRG Oncology researchers recently developed and validated a nomogram that can predict 2 - year and 5 - year overall survival (OS) and progression - free survival (PFS) for patients with local - regionally advanced oropharyngeal squamous cell carcinoma (OPSCC) treated primarily with radiation - based therapy.

Patients with squamous, adenocarcinoma and adenosquamous histologies and those with definite records defining local therapy were eligible for inclusion.

So the group set out to test whether selenium might reduce the chance of recurrence of basal cell or squamous cell carcinoma in people previously treated for skin cancer.

Lin Li, Primary Investigator of this project at BGI, said, «This is a great progress for genetic research of esophageal squamous cell cancer.

Interestingly, genomic analyses suggested that ESCC and head and neck squamous cell carcinoma (HNSCC) shared some common pathogenic mechanisms, and ESCC development is associated with alcohol drinking.These findings would provide a brand - new insight into the understandings of ESCC tumorigenesis, and would help clinicians to develop more effective diagnostic and therapeutic approaches for ESCC.

The FDA, in its warning letter to Meditherm, ordered the company to stop making broad claims about its cameras, pointing to a Web page that lists «76 specific conditions for which you say your device can be used... for example, lower motor neuron disease, neoplasias (melanoma, squamous cell, basal) and nutritional disease (alcoholism, diabetes).»

The FDA granted approval to nivolumab (Opdivo), an anti-PD-1 checkpoint inhibitor, for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) that has progressed despite platinum - based chemotherapy.

Pembrolizumab is approved for the treatment of both squamous and non-squamous non-small cell lung cancer (NSCLC) that is no longer responding to standard - of - care chemotherapy.

Phase II / III Biomarker - Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer

The FDA approved Opdivo ® (nivolumab) for the treatment of patients with metastatic squamous non-small cell lung cancer (NSCLC) after prior therapy.

The FDA granted accelerated approval to pembrolizumab (Keytruda), an anti-PD-1 checkpoint inhibitor, for patients with recurrent or metastatc head and neck squamous cell carcinoma (HNSCC).

Scholar - in - Training Awards in the amount of $ 1,000 for her submitted abstract entitled, «Activator protein 2 alpha (AP2α)- targeted methylation and silencing of relevant genes in head and neck squamous cell carcinoma (HNSCC) pathogenesis» to be presented at platform session at the 100th Annual Meeting of the American Association for Cancer Research, Denver, CO..

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single - arm trial.

Medical oncologist Alexander T. Pearson, MD, PhD cares for adults with head and neck cancers, especially squamous cell carcinoma, a common form of cancer that develops in the squamous cells that make up the middle and outer layer lining the mouth and throat.

After squamous cell carcinoma, melanoma is the second most common cancer of the vulva, accounting for 3.4 % to 10 % of vulvar malignancies.

Image cytometry of Cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.

For oral squamous cell carcinoma (OSCC), 50 % of patients develop secondary lesions (mainly in lymph nodes and / or lungs) with a 40 % overall survival rate.

In March, the U.S. Food and Drug Administration approved nivolumab for patients with advanced (metastatic) squamous non-small cell lung cancer.

Nomograms Developed and Validated for Patients with Squamous Cell Carcinoma of Larynx by NRG Oncology Read more

Assessment of predictive markers and patient stratification for treatment regimens for lung cancer: FGFR1 amplification is a potential driving oncogene in lung squamous cell cancer (SCC), a subtype of non-small cell lung carcinoma (NSCLC).

Currently, the CDK9 inhibitor flavopiridol is being evaluated in several phase I and II clinical trials for its anti-cancer effects either as a single agent or in combination with other drugs in treatment of esophageal cancer, B - cell chronic lymphocytic leukemia, endometrial carcinoma, recurrent / metastatic squamous cell carcinoma and most relevantly, previously treated locally advanced or metastatic breast cancer (http://www.cancernetwork.com/review-article/current-clinical-trials-flavopiridol/page/0/2).

The FDA approved two anti-PD-1 antibodies (nivolumab / Bristol - Myers Squibb and pembrolizumab / Merck & Co.) for metastatic melanoma in 2014, and it extended approval to metastatic squamous non-small cell lung cancer earlier this year.

«It could be either basal or squamous cell carcinoma, the two nonmelanoma forms of skin cancer,» says dermatologist Shawn Allen, MD, spokesperson for the Skin Cancer Foundation.

The researchers are investigating oesophageal squamous cell carcinoma, which accounts for 95 % of cases of oesophageal cancer around the world.

For skin cancers (basal cell carcinoma and squamous cell carcinoma), patients arinstructed to open the Laurose capsule and mix the powder with DMSO in gel form and a neutral cream, along with a drop of lavender essential oil and apply to the affected

Action spectra for UV - induced erythema, DNA damage, photoimmunesuppression, squamous cell carcinoma and vitamin D synthesis are very similar, all in the UVB spectral region of 280 - 310 nm.

Oral mouth cancer — squamous cell carcinoma — was higher for cats that live with smokers.

From horses with lameness issues that need treatment, to horses with severe fungus issues, eye injuries, emaciation, wounds, hernia surgeries, castrations, EPM treatment, squamous cell carcinoma, teeth floating, vaccinations, deworming, etc., our horses are our top priority and it takes a lot to properly care for so many rescued horses.

Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs.

Common oral tumors for both dogs and cats are squamous cell carcinoma, fibrosarcomas, and malignant melanomas1.

The group recently identified a genetic mutation for eye - related squamous cell carcinoma (SCC) in Haflinger horses, a breed with a higher reported incidence of SCC.

Researchers will investigate a new and promising treatment for oral squamous cell carcinoma, the most common oral cancer in cats.

The number of cats with mouth cancer, also known as squamous cell carcinoma, was higher for those animals living in smoking environments versus those felines living in a smoke - free home.

The prognosis for horses with squamous cell carcinoma is usually good if the tumor is small and can be completely excised.

Prognosis for cats with oral squamous cell carcinoma is poor with survival times usually ranging from 2 to 6 months.

secondhand smoke has been associated with oral squamous cell carcinoma, so it would be wise for owners to kick the habit — for themselves and their pups.